BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

IBP

All Eps Dividend Board Agm Q1 Q2 Q3

IBP 02-May-2021

(Q3 Un-audited): EPS was Tk. 0.12 for January-March 2021 as against Tk. 0.42 for January-March 2020; EPS was Tk. 0.79 for July 2020-March 2021 as against Tk. 1.24 for July 2019-March 2020. NOCFPS was Tk. 0.84 for July 2020-March 2021 as against Tk. 1.29 for July 2019-March 2020. NAV per share was Tk. 13.89 as on March 31, 2021 and Tk. 13.61 as on June 30, 2020. They also informed that reasons for shortfall in revenue due to suspension of production (Cont-1)

IBP 25-Apr-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2021 at 2:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

IBP 13-Apr-2021

Referring to their earlier letter no. IBPL/Board secretariat/DSE/news/2021/19 and news disseminated by DSE dated 23.03.2021 regarding suspending the production and marketing of all licensed items of lndo-Bangla Pharmaceuticals Ltd., the Company has informed that the Directorate General of Drug Administration (DGDA) has withdrawn the temporary suspension order of production and marketing of all licensed items by issued memo No. DGDA/ML-032/06/7151 on 12 April 2021.

IBP 28-Mar-2021

Mr. Md. Bellal Khan, one of the Sponsors of the Company, has further reported that he has completed his sell of 3,91,851 (Bonus) shares of the Company at prevailing market price through Stock Exchange (DSE) as per declaration disseminated on January 11, 2021.

IBP 23-Mar-2021

The company has informed that they have received a letter on March 07, 2021 from Directorate General of Drug Administration for temporary ban of company?s production and marketing. Therefore, the company instantly filed a writ petition against the mentioned order. They also informed that final hearing and date of order of honorable Court is scheduled to be held on April 04, 2021.

IBP 02-Feb-2021

The Company has informed that it has credited the Bonus shares for the year ended on June 30, 2020 to the respective shareholders' BO Accounts and it has also disbursed the cash dividend warrant to the respective shareholders through courier services.

IBP 28-Jan-2021

(Q2 Un-audited): EPS was Tk. 0.33 for October-December 2020 as against Tk. 0.44 for October-December 2019; EPS was Tk. 0.66 for July-December 2020 as against Tk. 0.83 for July-December 2019. NOCFPS was Tk. 0.68 for July-December 2020 as against Tk. 0.82 for July-December 2019. NAV per share was Tk. 13.77 as on December 31, 2020 and Tk. 13.61 as on June 30, 2020.

IBP 24-Jan-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2020.

IBP 11-Jan-2021

Mr. Md. Bellal Khan, one of the Sponsors of the Company, has expressed his intention to sell 3,91,851 (Bonus) shares out of his total holding of 37,64,860 shares of the Company at prevailing market price (in the Block Market) through Stock Exchange (DSE) within next 30 working days.

IBP 23-Nov-2020

Trading of the shares of the Company will resume on 24.11.2020 after record date.

Previous Next page